tbuckley/cabot-search huggingface dataset:
New Food Code Published: The FDA
Journal: JAMA (1994)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Corrigendum
Journal: BMJ (1945)

MED JURNLto be detected in the heart, then one need not restrict activity; probably exercise would improve the patient.It would be worth while knowing whether the blood pressure varied with the rate of the heart.It might be well to try full doses of strychnine, or some stimulant of the sympathetic such as ephedrine or amphetamine.Treatment of Eclampsia Q.-What is the modern treatment of eclampsia, occurring before the onset of, and during, labour?A.-The modern treatment of eclampsia' is based largely on the
Benign ulcer in the cancerous stomach
Authors: E. D. Palmer
Journal: JAMA (1974)

THE HISTORY of gastrology is shot through with uncertainties over the interrelationships of the benign and malignant diseases of the stomach. Most of the scriptive emphasis, of course, has centered on the difficulty of differentiating the benign ulcer from the malignant, a problem that will no doubt continue to plague the clinician as long as there are stomach diseases. Because occasional apparent diagnostic errors could not be explained in any other fashion, it was proposed long ago that some benign ulcers in time become malignant. Both pathologist and observant clinician have objected to this concept, and it is now thought that benign gastric ulcers never (or almost never) become malignant. A few observations have suggested another possible progression, the conversion of a gastric carcinoma to a benign crater through sloughing of the malignant portion. An association of malignant and benign that is more clear-cut concerns development of carcinoma in the
Evaluation of a New Antibacterial Agent
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Journal of Allergy, St. Louis
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Reference Citations and Figure Labeling
Authors: Susan Tolle, Alvin Moss, Susan Hickman
Journal: JAMA (2016)

Antoni Ribas, MD, PhD; Omid Hamid, MD; Adil Daud, MD; F. Stephen Hodi, MD; Jedd D. Wolchok, MD, PhD; Richard Kefford, MD, PhD; Anthony M. Joshua, MBBS, PhD; Amita Patnaik, MD; Wen-Jen Hwu, MD, PhD; Jeffrey S. Weber, MD, PhD; Tara C. Gangadhar, MD; Peter Hersey, MD, PhD; Roxana Dronca, MD; Richard W. Joseph, MD; Hassane Zarour, MD; Bartosz Chmielowski, MD, PhD; Donald P. Lawrence, MD; Alain Algazi, MD; Naiyer A. Rizvi, MD; Brianna Hoffner, BA, RN, MSN; Christine Mateus, MD; Kevin Gergich, MA; Jill A. Lindia, MS; Maxine Giannotti, BS; Xiaoyun Nicole Li, PhD; Scot Ebbinghaus, MD; S. Peter Kang, MD; Caroline Robert, MD, PhD
Massive pulmonary thromboembolism. Experience with 12 pulmonary embolectomies
Authors: R. D. Sautter
Journal: JAMA (1965)

In a series of 12 pulmonary embolectomies, there were three survivors, none of whom was over 65 years of age. The principal cause of death in the patients who did not survive was cardiovascular collapse of undetermined etiology. Sustained peripheral hypotension was used as the indication for surgical intervention. Embolectomy in other than life-threatening situations is probably unwarranted. Pulmonary arteriography should confirm the diagnosis prior to embolectomy. Cardiac arrest, which occurred in over half of the patients in this series, can be prevented or adequately managed by peripheral cannulization and partial cardiopulmonary bypass prior to thoracotomy. Cardiopulmonary bypass, because it provides adequate time for a deliberate attack, is the modality of choice for the removal of the emboli. The inferior vena cava should be ligated at the time of embolectomy to prevent further embolization.
Variant Angina
Authors: ABDUL H. KHAN
Journal: Annals of Internal Medicine (1972)

Letters, Comments, and Corrections1 February 1972Variant AnginaABDUL H. KHAN, M.D., ARTHUR B. LANDRY JR., M.D.ABDUL H. KHAN, M.D.Search for more papers by this author, ARTHUR B. LANDRY JR., M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-76-2-335 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: The observation by Silverman and Flamm (1) that patients with Prinzmetal variant angina have a high incidence of subsequent myocardial infarction has an important bearing on their management. This case is pertinent.Patient P.S., a 55-year-old man, had had recurrent intermittent anginal chest pain for about 3 weeks, occurring mostly in the early morning hours and awakening him. He had been admitted to another hospital, where study findings including exercise stress, electrocardiography, and enzymes were reported to be normal. He was referred to St. Francis Hospital for possible coronary arteriography. His admission ECG, chest X-ray, enzyme studies,...References1. SILVERMAN M and FLAMM M: Variant angina pectoris. Ann Intern Med 75:339-343, 1971 LinkGoogle Scholar2. GUAZZI M, FIORENTINI A, and MAGRINI F: Continuous electrocardiographic recording in Prinzmetal's variant angina pectoris. A report of four cases Br Heart J 32:611-616, 1970 CrossrefMedlineGoogle Scholar3. LUNGER M and SHAPIRO A: Continuous electrocardiographic monitoring in nocturnal angina (abstract). Am J Cardiol 13:119, 1964 CrossrefGoogle Scholar4. ROBINSON J: Prinzmetal's variant angina pectoris. Report of a case. Am Heart J 70:797-800, 1965 CrossrefMedlineGoogle Scholar5. PRINTZMETAL M, KENNAMER R, and MERLISS R: Angina pectoris. I. A variant form of angina pectoris. Am J Med 27:375-388, 1959 CrossrefMedlineGoogle Scholar6. SPODICK D: Revascularization of the heart-numerators in search of denominators. Am Heart J 81:149-157, 1971 CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ABDUL H. KHAN, M.D.; ARTHUR B. LANDRYJR., M.D. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySignificance of episodic painless ST segment elevation at rest in ischemic heart disease 1 February 1972Volume 76, Issue 2Page: 335-335KeywordsAnginaAngiographyElectrocardiographyEnzymesExerciseIschemiaMyocardial infarctionStable coronary artery diseaseThorax ePublished: 1 December 2008 Issue Published: 1 February 1972 PDF downloadLoading ...
La Rachitide e le deformita da essa prodotte.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Semiquantitative Estimation of the Two Serum Immunoglobulins β2A and β2M During the Neonatal Period and During Childhood
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Editorial: Coping with the energy crisis: midwestern style (with a couple of asides)
Authors: M. T. Southgate
Journal: JAMA (1974)

We have duly noted and much admired Franz Ingelfinger's editorial in the<i>New England Journal of Medicine</i>taking the government to task for permitting the standards set by the Clean Air Act of 1970 to be lowered in the face of the present energy crisis.<sup>1</sup>He also seriously questioned whether office temperatures of 72 to 75 F do really go hand in hand with health. We cannot take exception to either of his points. While perhaps not as prompt in writing about the energy crisis, the American Medical Association has acted with alacrity in instituting some practical measures to ease the drain on fuel supplies available to this country. On Nov 14, all division directors and department managers were notified that during working hours "temperatures within the headquarters building will be reduced from 4 to 6 degrees to an average temperature of 69 degrees." Considering that the building is
NEWLY DISCOVERED FACTORS IN NATURAL IMMUNITY
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Endowments.—
Journal: JAMA (1883)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 2185: Informatics framework for clustering and deriving gene signatures for prognostic stratification of cancer patients
Authors: Segun Jung, Yingtao Bi, Ramana V. Davuluri
Journal: Cancer Research (2015)

Abstract Stratification of cancer patients into different molecular groups is essential for developing targeted therapies. High-throughput technologies, such as microarrays and next-generation sequencing, have been extensively used for generating multi-omics data. Indeed, The Cancer Genome Atlas (TCGA) consortium, one of the most comprehensive and popular databases of cancer, has been accumulating large volumes of invaluable data for more than 30 cancer types, offering unprecedented opportunity to attain new insights in cancer biology. Despite the technological advances, analyzing, integrating and translating the gene signatures across different platforms remains a computationally challenging task. Here, we developed a novel computational framework that integrates genomic and clinical data to stratify cancer patients into different molecular subgroups and predict clinically applicable phenotypes, such as survival. Application of this user-friendly framework derives platform-independent isoform-level gene signatures that can be translated from high-dimensional platforms (e.g., RNA-Seq) to clinically adaptable low-dimensional molecular assays (e.g., RT-PCR) for prognostic stratification. We applied the pipeline on two TCGA lung cancer datasets_Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC). Using independent test data, we achieved about 93% (LUAD) and 98% (LUSC) classification accuracy using less than 70 isoform-level gene signature. The proposed informatics platform is applicable to other cancer types in TCGA data portal. Note: This abstract was not presented at the meeting. Citation Format: Segun Jung, Yingtao Bi, Ramana V. Davuluri. Informatics framework for clustering and deriving gene signatures for prognostic stratification of cancer patients. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2185. doi:10.1158/1538-7445.AM2015-2185
Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy.
Authors: Paul Nghiem, Shailender Bhatia, Evan J. Lipson, William Howard Sharfman, Ragini Reiney Kudchadkar, Philip Adam Friedlander, Andrew Scott Brohl, Adil Daud, Harriet M. Kluger, Sunil A. Reddy, Melissa Amber Burgess, Brent Allen Hanks, Thomas Olencki, Brian C. Boulmay, Lisa M Lundgren, Nirasha Ramchurren, Blanca Homet Moreno, Elad Sharon, Martin A. Cheever, Suzanne Louise Topalian
Journal: Journal of Clinical Oncology (2018)

9506 Background: Merkel cell carcinoma (MCC) is an aggressive skin cancer often caused by the Merkel cell polyomavirus (MCPyV). Clinical trials of PD-1-axis blocking agents in aMCC have demonstrated increased progression free survival (PFS) compared to historical data from patients (pts) receiving chemotherapy, but data on response durability and OS are limited. Here we report outcomes from the expanded phase 2 Cancer Immunotherapy Trials Network-09 trial of pembrolizumab (PEM, anti-PD-1) in the first-line setting (NCT02267603). Methods: Adults with aMCC, naïve to systemic therapy for aMCC, received PEM (2 mg/kg Q3W) for up to 2 yrs. Responses per RECIST v1.1 were assessed centrally based on CT scans performed at 12 wks and Q9W thereafter. Tumor MCPyV status was assessed by serum antibody titer and/or IHC for MCPyV oncoprotein. Preliminary results from the first 26 pts have been reported (Nghiem NEJM 2016). We now include data from an expansion cohort of 24 pts. Results: 50 pts (43 stage IV, 7 unresectable stage IIIB) were enrolled 01/2015 – 05/2017. 80% of pts were ≥65 yrs of age. As of 06/21/17, median follow-up was 8.6 mo (range 0.4 - 29 mo). Among tumors from 49 pts, 65% were MCPyV+. Of 42 pts with ≥21 wk follow-up, confirmed ORR was 50% (95% CI 34.2-65.8; CR 19%, PR 31%). ORR was 52% and 44% in pts with MCPyV (+) and (-) tumors, respectively. Median PFS was not reached (NR; 95% CI 2.9 mo - Not Estimable). OS rate at 18 mo was 68% and median OS was NR, comparing favorably to historical first-line chemotherapy data (18 mo OS rate ~30%; Iyer 2016 & Cowey 2017). Among 21 confirmed responders, median response duration was NR (range 3.9+ to 25.6+ mo). Treatment-related adverse events (TRAE) of any grade (CTCAE v4.0) were seen in 47/50 pts (94%); 15 pts (30%) experienced a grade ≥3 TRAE, including 1 treatment-related death. TRAEs led to discontinuing PEM in 6 pts (12%). Conclusions: These results represent the longest observation to date of patients with aMCC receiving first-line anti-PD-1, and demonstrate durable tumor control, a favorable OS rate, and a manageable safety profile. An additional 7.5 mos of follow-up and correlative studies including tumor PD-L1 expression will be presented. Clinical trial information: NCT02267603.
TREATMENT OF INFECTIONS WITH S.U.P. 36
Authors: E. H. Richards
Journal: BMJ (1929)

It is believed that odor transduction in the mammalian main olfactory system only involves the cAMP-signaling pathway. Here, we report on odor responsiveness in mice with a disrupted cyclic nucleotide-gated (CNG) channel subunit A2. Several odorants, including putative pheromones, can be detected and discriminated by these mice behaviorally. These odors elicit responses in the olfactory epithelium, main olfactory bulb, and olfactory (piriform) cortex of CNGA2 knock-out mice. In addition, responses to odors detected by CNGA2 knock-out mice are relatively insensitive to inhibitors of the cAMP pathway. These results provide strong evidence that cAMP-independent pathways in the main olfactory system of mammals participate in detecting a subset of odors.
Rapid Tranquilization
Authors: PAUL POLAK, LAWRENCE LAYCOB
Journal: American Journal of Psychiatry (1971)

The authors describe a treatment of acute schizophrenia that combines drug therapy and psychotherapy. Patients are rapidly tranquilized by titrating dosage levels of phenothiazines administered every one or two hours against the patient's specific target symptoms to produce a tranquilized end point within six hours. Dosage levels are adjusted daily and chemotherapy is integrated with intensive social-systems intervention centered on the patient's real-life setting.
AMA Science Reporters' Conference explores wide range of clinical problems, approaches
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal